BiPAD®, Inc., has engaged TriPoint GLobal Equities, LLC.

​BiPAD ® , LLC has engaged Tripoint Global Equities, LLC as a placement agent to initiate a $1.5M capital raise. This seed round will fund manufacturing for 510K FDA certification and beta testing of the BiPAD bipolar electrocautery forceps cord with integrated hand switch.

​TriPoint Global Equities is a global investment bank focused on assisting fast growing companies. 

Please fill the following details and we will get in touch with you. (*Required)
How did you hear about BiPAD®?
Subscribe to BiPAD® Newsletter
  • LinkedIn - White Circle
  • Facebook
  • Instagram
  • Twitter